We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Revolutionary Surgery Closure Device Could Reduce Patient Visits to OR

By HospiMedica International staff writers
Posted on 20 Feb 2023

Almost one in five open abdomen procedures in the US are left intentionally open for further treatment and later closed. More...

However, a huge 38% of these "fail to close", resulting in additional visits to the operating room (OR) for sequential closure. This creates the risks of infection, prolonged time on a ventilator, loss of domain, increased attendant time, increased OR time, and even mortality, thereby adding a costly burden to the healthcare system. Now, an innovative device offers a non-invasive method for closing an open abdominal incision without surgery at the patient’s bedside, thereby improving patient safety and experience, while freeing up OR staff for other procedures.

InventoRR MD’s (Toronto, ON, Canada) flagship device, the AbClo, helps to facilitate primary closure of open abdomens and prevents loss of domain allowing surgeons to achieve closure successfully and on their timelines preventing negative patient outcomes and saving institutions time and money. AbClo works like a corset, supporting and stabilizing the abdominal wall to prevent damage and restore the equilibrium of the muscles in the torso. It can be applied in the ICU where it is sequentially tightened at the bedside so that the edges of the abdominal wall can meet in the middle for reattachment. While prescribed by a physician, it can be applied and monitored by other authorized healthcare providers, such as nurses. AbClo is licensed by Health Canada and the FDA.

“AbClo was developed to improve patient outcomes and make the post-surgical process easier for medical teams,” said InventoRR MD CEO Chris Bass.

Related Links:
InventoRR MD


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researcher Nick Housley examines microscopic nanohydrogels, gel-like particles designed to carry drugs through the bloodstream (Photo courtesy of Georgia Tech)

Nanohydrogels Guide Medicine to Tumors Without Damaging Healthy Tissue

Many cancer treatments are effective at destroying tumors but can also damage healthy tissue, causing severe side effects for patients. This occurs because conventional chemotherapy drugs circulate throughout... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.